Literature DB >> 15811644

Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis.

Natalia Reszka1, Jan B W J Cornelissen, Michiel M Harmsen, Krystyna Bieńkowska-Szewczyk, Joop de Bree, Wim J Boersma, Frans A M Rijsewijk.   

Abstract

Fasciola hepatica juveniles express immunodominant cathepsin L proteins, which are mainly found in their immature, procathepsin form. A gene encoding such a procathepsin L (FheCL3) was expressed by a baculovirus recombinant and by Saccharomyces cerevisiae. The glycosylated FheCL3 proteins obtained by both systems were used in a vaccination/challenge experiment in rats. Both antigens evoked similar antibody responses, but only the baculovirus expressed FheCL3 caused a significant protection against the number of liver flukes (52% protection, P=0.01), whereas the S. cerevisiae expressed FheCL3 did not. In a second experiment in rats, deglycosylated versions of both antigens were used, but this did not improve their efficacies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811644     DOI: 10.1016/j.vaccine.2004.12.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies.

Authors:  Krai Meemon; Prasert Sobhon
Journal:  Parasitol Res       Date:  2015-06-24       Impact factor: 2.289

2.  Design of a Peptide-Carrier Vaccine Based on the Highly Immunogenic Fasciola hepatica Leucine Aminopeptidase.

Authors:  Cecilia Salazar; José F Tort; Carlos Carmona
Journal:  Methods Mol Biol       Date:  2020

3.  Towards delineating functions within the fasciola secreted cathepsin l protease family by integrating in vivo based sub-proteomics and phylogenetics.

Authors:  Russell M Morphew; Hazel A Wright; E James Lacourse; Joanne Porter; John Barrett; Debra J Woods; Peter M Brophy
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

4.  Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches.

Authors:  Lilian Hernández Alvarez; Dany Naranjo Feliciano; Jorge Enrique Hernández González; R O Soares; Rosemberg de Oliveira Soares; Diego Enry Barreto Gomes; Pedro Geraldo Pascutti
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

Review 5.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

6.  Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis.

Authors:  Ana M Espino; Francheska Rivera
Journal:  Vet Parasitol       Date:  2009-12-22       Impact factor: 2.738

7.  Tegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycans.

Authors:  Andres Garcia-Campos; Alessandra Ravidà; D Linh Nguyen; Krystyna Cwiklinski; John P Dalton; Cornelis H Hokke; Sandra O'Neill; Grace Mulcahy
Journal:  PLoS Negl Trop Dis       Date:  2016-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.